The Oncology Institute, Inc.
TOI
$2.78
-$0.015-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.57% | 18.19% | -4.10% | 22.17% | -6.05% |
| Total Depreciation and Amortization | 4.51% | 8.52% | 3.62% | 1.95% | -5.58% |
| Total Amortization of Deferred Charges | 205.77% | 0.44% | 1.41% | 0.38% | -0.83% |
| Total Other Non-Cash Items | 260.84% | -42.27% | 1,526.06% | -96.15% | -29.93% |
| Change in Net Operating Assets | -75.43% | 11.09% | 436.55% | -24.67% | -142.38% |
| Cash from Operations | -219.16% | 411.11% | 105.23% | 1.40% | -307.99% |
| Capital Expenditure | 81.31% | -536.57% | 122.02% | -199.34% | 29.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -50.00% | 0.02% | 58.16% |
| Cash from Investing | 88.49% | -116.87% | -42.77% | -6.25% | 66.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,635.51% | -217.66% | 11,111.11% | 99.11% | 69.17% |
| Issuance of Common Stock | -- | -- | -100.00% | -97.26% | -35.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 181.20% | 42.34% | -- | -- |
| Cash from Financing | -2,790.24% | 32.51% | 88.68% | -128.89% | 47.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -538.02% | -79.35% | 2,875.07% | -85.63% | -56.88% |